Literature DB >> 10201844

Synthesis and biological activity of oxo-7H-benzo[e]perimidine-4-carboxylic acid derivatives as potent, nonpeptide corticotropin releasing factor (CRF) receptor antagonists.

D R Luthin1, A K Rabinovich, D R Bhumralkar, K L Youngblood, R A Bychowski, D S Dhanoa, J M May.   

Abstract

A novel series of derivatives of oxo-7H-benzo[e]perimidine-4-carboxylic acid (I) potently displaced radioligand binding of 125I-CRF to both CRF1 and CRF2 receptors. The members of this series antagonized CRF-stimulated cAMP formation and CRF-stimulated corticotropin release from rat pituitary in vivo. These are the first nonpeptide antagonists to show activity at both CRF1 and CRF2 receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201844     DOI: 10.1016/s0960-894x(99)00075-x

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Fe3O4/SO3H@zeolite-Y as a novel multi-functional and magnetic nanocatalyst for clean and soft synthesis of imidazole and perimidine derivatives.

Authors:  Mehdi Kalhor; Zohre Zarnegar
Journal:  RSC Adv       Date:  2019-06-20       Impact factor: 4.036

2.  Synthesis of 2-phenylazonaphtho[1,8-ef][1,4]diazepines and 9-(3-arylhydrazono)pyrrolo[1,2-a]perimidines as antitumor agents.

Authors:  Thoraya A Farghaly; Eman M H Abbas; Kamal M Dawood; Tarek B A El-Naggar
Journal:  Molecules       Date:  2014-01-08       Impact factor: 4.411

3.  Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway.

Authors:  Bingbing Dai; Jithesh J Augustine; Ya'an Kang; David Roife; Xinqun Li; Jenying Deng; Lin Tan; Leona A Rusling; John N Weinstein; Philip L Lorenzi; Michael P Kim; Jason B Fleming
Journal:  Cell Death Dis       Date:  2021-07-10       Impact factor: 8.469

Review 4.  Recent Advances in the Synthesis of Perimidines and their Applications.

Authors:  Nusrat Sahiba; Shikha Agarwal
Journal:  Top Curr Chem (Cham)       Date:  2020-08-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.